Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 435

1.

Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer.

Zhou M, Jiang Z, Epstein JI.

Am J Surg Pathol. 2003 Jun;27(6):772-8.

PMID:
12766580
[PubMed - indexed for MEDLINE]
2.

Alpha-methylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy.

Magi-Galluzzi C, Luo J, Isaacs WB, Hicks JL, de Marzo AM, Epstein JI.

Am J Surg Pathol. 2003 Aug;27(8):1128-33.

PMID:
12883245
[PubMed - indexed for MEDLINE]
3.

How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers?

Zhou M, Aydin H, Kanane H, Epstein JI.

Am J Surg Pathol. 2004 Feb;28(2):239-43.

PMID:
15043314
[PubMed - indexed for MEDLINE]
4.

Diagnostic utility of a p63/alpha-methyl-CoA-racemase (p504s) cocktail in atypical foci in the prostate.

Molinié V, Fromont G, Sibony M, Vieillefond A, Vassiliu V, Cochand-Priollet B, Hervé JM, Lebret T, Baglin AC.

Mod Pathol. 2004 Oct;17(10):1180-90.

PMID:
15205683
[PubMed - indexed for MEDLINE]
Free Article
5.

Comparison of monoclonal antibody (P504S) and polyclonal antibody to alpha methylacyl-CoA racemase (AMACR) in the work-up of prostate cancer.

Kunju LP, Chinnaiyan AM, Shah RB.

Histopathology. 2005 Dec;47(6):587-96.

PMID:
16324196
[PubMed - indexed for MEDLINE]
6.

Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens.

Browne TJ, Hirsch MS, Brodsky G, Welch WR, Loda MF, Rubin MA.

Hum Pathol. 2004 Dec;35(12):1462-8.

PMID:
15619204
[PubMed - indexed for MEDLINE]
7.

Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.

Sung MT, Jiang Z, Montironi R, MacLennan GT, Mazzucchelli R, Cheng L.

Hum Pathol. 2007 Feb;38(2):332-41. Epub 2006 Nov 28.

PMID:
17134736
[PubMed - indexed for MEDLINE]
8.

Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.

Luo J, Zha S, Gage WR, Dunn TA, Hicks JL, Bennett CJ, Ewing CM, Platz EA, Ferdinandusse S, Wanders RJ, Trent JM, Isaacs WB, De Marzo AM.

Cancer Res. 2002 Apr 15;62(8):2220-6.

PMID:
11956072
[PubMed - indexed for MEDLINE]
Free Article
9.

Detection of prostate cancer by alpha-methylacyl CoA racemase (P504S) in needle biopsy specimens previously reported as negative for malignancy.

Carswell BM, Woda BA, Wang X, Li C, Dresser K, Jiang Z.

Histopathology. 2006 May;48(6):668-73.

PMID:
16681682
[PubMed - indexed for MEDLINE]
10.

Analysis of alpha-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia.

Wu CL, Yang XJ, Tretiakova M, Patton KT, Halpern EF, Woda BA, Young RH, Jiang Z.

Hum Pathol. 2004 Aug;35(8):1008-13.

PMID:
15297968
[PubMed - indexed for MEDLINE]
11.

P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies.

Beach R, Gown AM, De Peralta-Venturina MN, Folpe AL, Yaziji H, Salles PG, Grignon DJ, Fanger GR, Amin MB.

Am J Surg Pathol. 2002 Dec;26(12):1588-96.

PMID:
12459625
[PubMed - indexed for MEDLINE]
12.

Foamy gland carcinoma of the prostate in needle biopsy: incidence, Gleason grade, and comparative α-methylacyl-CoA racemase vs. ERG expression.

Warrick JI, Humphrey PA.

Am J Surg Pathol. 2013 Nov;37(11):1709-14. doi: 10.1097/PAS.0b013e318293d85b.

PMID:
23797726
[PubMed - indexed for MEDLINE]
13.

Immunohistochemistry in diagnostic surgical pathology of the prostate.

Hameed O, Humphrey PA.

Semin Diagn Pathol. 2005 Feb;22(1):88-104. Review.

PMID:
16512601
[PubMed - indexed for MEDLINE]
14.

Alpha-methylacyl-CoA racemase (AMACR) in fine-needle aspiration specimens of prostate lesions.

Kaić G, Tomasović-Loncarić C.

Diagn Cytopathol. 2009 Nov;37(11):803-8. doi: 10.1002/dc.21103.

PMID:
19459159
[PubMed - indexed for MEDLINE]
16.

alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.

Rubin MA, Zhou M, Dhanasekaran SM, Varambally S, Barrette TR, Sanda MG, Pienta KJ, Ghosh D, Chinnaiyan AM.

JAMA. 2002 Apr 3;287(13):1662-70.

PMID:
11926890
[PubMed - indexed for MEDLINE]
17.

Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.

Leav I, McNeal JE, Ho SM, Jiang Z.

Hum Pathol. 2003 Mar;34(3):228-33.

PMID:
12673556
[PubMed - indexed for MEDLINE]
18.

Utility of alpha-methylacyl coenzyme A racemase (p504s antibody) as a diagnostic immunohistochemical marker for cancer.

Nassar A, Amin MB, Sexton DG, Cohen C.

Appl Immunohistochem Mol Morphol. 2005 Sep;13(3):252-5.

PMID:
16082251
[PubMed - indexed for MEDLINE]
20.

Sensitivity of P504S/alpha-methylacyl-CoA racemase (AMACR) immunohistochemistry for the detection of prostate carcinoma on stored needle biopsies.

Vanguri VK, Woda BA, Jiang Z.

Appl Immunohistochem Mol Morphol. 2006 Sep;14(3):365-8.

PMID:
16932031
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk